Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-03 · accession 0001711462-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-03 | ANAB | Lizzul Paul F. | Chief Medical Off | M - OptEx | — | +10.6K | 37.5K | +39% | — |
| D | 2026-01-06 | 2026-01-05 | ANAB | Lizzul Paul F. | Chief Medical Off | S - Sale+OE | $43.26 | -4,219 | 33.3K | -11% | -$182.5K |
| D | 2026-01-06 | 2026-01-03 | ANAB | Lizzul Paul F. | Chief Medical Off | M - OptEx | $0.00 | -10.6K | 21.1K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-03 | M | A | 10,555 | — | 37,522 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. |
| 2 | Common | Common Stock | 2026-01-05 | S | D | 4,219 | $43.26 | 33,303 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-01-03 | M | D | 10,555 | $0.00 | 21,110 | D | — · — to — | 10,555 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. (F3) The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |